Therefore, it is possible that parkin KO reduced p21 ubiquitination and degradation, leading to increased p21/CDK2 or p21/PCNA complex association, which ultimately resulted in the inhibition of tumor growth through cell cycle arrest. The gene discussed is PCNA; the disease is neoplasm.